IN191811B - - Google Patents

Info

Publication number
IN191811B
IN191811B IN937DE1999A IN191811B IN 191811 B IN191811 B IN 191811B IN 937DE1999 A IN937DE1999 A IN 937DE1999A IN 191811 B IN191811 B IN 191811B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Shakti Nath Upadhyay
D N K Sarma
Nalini Wali
N K Saraswathi
Original Assignee
Nat Inst Immunology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Inst Immunology filed Critical Nat Inst Immunology
Priority to IN937DE1999 priority Critical patent/IN191811B/en
Publication of IN191811B publication Critical patent/IN191811B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN937DE1999 1996-02-14 1999-06-30 IN191811B (cs)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN937DE1999 IN191811B (cs) 1996-02-14 1999-06-30

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN294DE1996 IN184685B (cs) 1996-02-14 1996-02-14
IN937DE1999 IN191811B (cs) 1996-02-14 1999-06-30

Publications (1)

Publication Number Publication Date
IN191811B true IN191811B (cs) 2004-01-03

Family

ID=11089150

Family Applications (2)

Application Number Title Priority Date Filing Date
IN294DE1996 IN184685B (cs) 1996-02-14 1996-02-14
IN937DE1999 IN191811B (cs) 1996-02-14 1999-06-30

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IN294DE1996 IN184685B (cs) 1996-02-14 1996-02-14

Country Status (2)

Country Link
US (2) US6245781B1 (cs)
IN (2) IN184685B (cs)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8147824B2 (en) * 1999-08-05 2012-04-03 Athersys, Inc. Immunomodulatory properties of multipotent adult progenitor cells and uses thereof
US8142819B2 (en) * 2002-10-21 2012-03-27 Metaproteomics, Llc Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response
US20040115290A1 (en) * 2001-06-20 2004-06-17 Tripp Matthew L. Modulation of inflammation by hops fractions and derivatives
US7666449B2 (en) * 2001-06-20 2010-02-23 Metaproteomics, Llc Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity
US7901714B2 (en) * 2001-06-20 2011-03-08 Metaproteomics, Llp Treatment modalities for autoimmune diseases
US7901713B2 (en) * 2001-06-20 2011-03-08 Metaproteomics, Llc Inhibition of COX-2 and/or 5-LOX activity by fractions isolated or derived from hops
US8206753B2 (en) * 2001-06-20 2012-06-26 Metaproteomics, Llc Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetes
US8168234B2 (en) * 2001-06-20 2012-05-01 Metaproteomics, Llc Compositions that treat or inhibit pathological conditions associated with inflammatory response
US6638981B2 (en) 2001-08-17 2003-10-28 Epicept Corporation Topical compositions and methods for treating pain
US8158160B2 (en) * 2001-11-13 2012-04-17 Eric Hauser Kuhrts Anti-inflammatory cyclooxygenase inhibitors
US20040071666A1 (en) * 2002-05-24 2004-04-15 The Regents Of The University Of Michigan Compositions and methods related to graft-versus-host disease
CN1324026C (zh) * 2002-09-23 2007-07-04 东北制药总厂 硫酸黄连素的制备方法
MXPA05004288A (es) * 2002-10-21 2005-08-02 Metaproteomics Llc Composiciones para tratar o inhibir los estados patologicos asociados con la respuesta inflamatoria.
CA2526804A1 (en) 2003-05-22 2005-05-06 Metaproteomics, Llc Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity
US7914831B2 (en) * 2004-02-27 2011-03-29 Metaproteomics, Llc Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines
US20050192356A1 (en) * 2004-02-27 2005-09-01 Babish John G. Synergistic anti-inflammatory pharmaceutical compositions and methods of use
EP1817941A4 (en) * 2004-11-13 2009-11-11 Metaproteomics Llc CYCLOOXYGENASE-2 INHIBITION COMPOSITIONS
US8263139B2 (en) * 2005-08-09 2012-09-11 Metaproteonics, Llc Protein kinase modulation by hops and Acacia products
US11000546B2 (en) 2005-11-09 2021-05-11 Athersys, Inc. Immunomodulatory properties of MAPCs and uses thereof
US10117900B2 (en) 2005-11-09 2018-11-06 Athersys, Inc. MAPC treatment of brain injuries and diseases
EP1976552A4 (en) * 2005-12-09 2009-09-16 Metaproteomics Llc MODULATION OF PROTEIN KINASE WITH HOP AND ACACIA PRODUCTS
DK1986668T3 (da) 2006-01-23 2013-09-02 Athersys Inc MAPC-terapi uden immunundertrykkende tillægsbehandling
US20080124404A1 (en) * 2006-06-19 2008-05-29 Jingwen Liu Hypolipidemic and/or hypocholesteremic compounds obtainable from the goldenseal plant
US20080051466A1 (en) * 2006-06-20 2008-02-28 Metaproteomics, Llc Isoalpha acid based protein kinase modulation cancer treatment
CN101505770A (zh) * 2006-06-20 2009-08-12 麦特普罗泰欧米克斯有限公司 基于还原异α酸蛋白激酶调节的癌症治疗
CN100431542C (zh) * 2006-11-07 2008-11-12 暨南大学 育亨宾和小檗碱混合在制药中的应用
JP2010522190A (ja) 2007-03-19 2010-07-01 メタプロテオミクス， エルエルシー 骨及び関節の健康を助成するための方法と組成物
EP2152684A4 (en) 2007-05-11 2011-05-18 Metaproteomics Llc METHOD AND COMPOSITIONS FOR THE DETOXIFICATION OF HEAVY METAL
AU2008335156A1 (en) * 2007-12-10 2009-06-18 Metaproteomics, Llc Substituted 1,3-cyclopentadione multi-target protein kinase modulators of cancer, angiogenesis and the inflammatory pathways associated therewith
EP2254420A4 (en) 2008-02-20 2012-02-15 Targia Pharmaceuticals CNS PHARMACEUTICALS AND METHOD FOR THEIR USE
JP2011516492A (ja) * 2008-04-02 2011-05-26 メタプロテオミクス， エルエルシー 内皮炎症及び内皮−単球相互作用の置換１，３−シクロペンタジオンによる減弱
CN103181896B (zh) * 2011-12-30 2015-10-14 沈阳药科大学 一种含有小檗胺类药物的脂质体制剂及其制备方法
US10500169B2 (en) * 2014-09-17 2019-12-10 Xiu-Min Li Supression of IgE production by compounds derived from traditional chinese medicine
KR101852148B1 (ko) 2015-06-26 2018-04-25 한국생명공학연구원 타입 III 에펙터 HopQ1 및 LIM 도메인 키나아제1(LIMK1)의 상호작용을 이용한 HopQ1에 의한 면역 억제에 대한 억제제 스크리닝 방법 및 이를 위한 조성물
ES2926179T3 (es) 2016-11-24 2022-10-24 Sigmadrugs Kutato Korlatolt Feleloessegue Tarsasag Utilización de composiciones para la conservación de órganos/tejidos
CN111053770B (zh) * 2019-12-23 2023-04-14 厦门大学 黄连素作为同种异体心脏移植中所使用的免疫抑制剂的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07315051A (ja) * 1994-05-20 1995-12-05 Shuji Hashimoto 自動車乗降時の日除け雨除け用装置
JPH07316051A (ja) * 1994-05-23 1995-12-05 Kanegafuchi Chem Ind Co Ltd 免疫抑制剤としてのベルベリン

Also Published As

Publication number Publication date
IN184685B (cs) 2000-09-23
US6245781B1 (en) 2001-06-12
US6291483B1 (en) 2001-09-18

Similar Documents

Publication Publication Date Title
IN189555B (cs)
IN190706B (cs)
ITAN960009A0 (cs)
IN191811B (cs)
ITMI960357A0 (cs)
IN190710B (cs)
IN187739B (cs)
IN191618B (cs)
ITGE960004A0 (cs)
ITMI960233A0 (cs)
IN182759B (cs)
ITMI960538V0 (cs)
IN186635B (cs)
IN189400B (cs)
ITMI960479A0 (cs)
ITMI960517V0 (cs)
ITMI960631V0 (cs)
CN3044173S (cs)
CN3040543S (cs)
CN3043415S (cs)
CN3043418S (cs)
CN3044168S (cs)
CN3044169S (cs)
CN3044347S (cs)
CN3044170S (cs)